-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
-
Summary
-
Ngm Biopharmaceuticals Inc quarterly Common Stock, Value, Issued history and growth rate from Q4 2018 to Q4 2023.
- Ngm Biopharmaceuticals Inc Common Stock, Value, Issued for the quarter ending December 31, 2023 was $83K, a 1.22% increase year-over-year.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)